Cited 0 times in Scipus Cited Count

3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis

Authors
Jeon, J | Kang, LJ  | Lee, KM | Cho, C | Song, EK | Kim, W | Park, TJ | Yang, S
Citation
Journal of cellular and molecular medicine, 22(1). : 57-66, 2018
Journal Title
Journal of cellular and molecular medicine
ISSN
1582-18381582-4934
Abstract
3'-Sialyllactose has specific physiological functions in a variety of tissues: however, its effects on osteoarthritic development remain unknown. Here, we demonstrated the function of 3'-sialyllactose on osteoarthritic cartilage destruction. In vitro and ex vivo, biochemical and histological analysis demonstrated that 3'-sialyllactose was sufficient to restore the synthesis of Col2a1 and accumulation of sulphated proteoglycan, a critical factor for cartilage regeneration in osteoarthritic development, and blocked the expression of Mmp3, Mmp13 and Cox2 induced by IL-1beta, IL-6, IL-17 and TNF-alpha, which mediates cartilage degradation. Further, reporter gene assays revealed that the activity of Sox9 as a transcription factor for Col2a1 expression was accelerated by 3'-sialyllactose, whereas the direct binding of NF-kappaB to the Mmp3, Mmp13 and Cox2 promoters was reduced by 3'-sialyllactose in IL-1beta-treated chondrocytes. Additionally, IL-1beta induction of Erk phosphorylation and IkappaB degradation, representing a critical signal pathway for osteoarthritic development, was totally blocked by 3'-sialyllactose in a dose-dependent manner. In vivo, 3'-sialyllactose protected against osteoarthritic cartilage destruction in an osteoarthritis mouse model induced by destabilization of the medial meniscus, as demonstrated by histopathological analysis. Our results strongly suggest that 3'-sialyllactose may ameliorate osteoarthritic cartilage destruction by cartilage regeneration via promoting Col2a1 production and may inhibit cartilage degradation and inflammation by suppressing Mmp3, Mmp13 and Cox2 expression. The effects of 3'-sialyllactose could be attributed in part to its regulation of Sox9 or NF-kappaB and inhibition of Erk phosphorylation and IkappaB degradation. Taken together, these effects indicate that 3'-sialyllactose merits consideration as a natural therapeutic agent for protecting against osteoarthritis.
Keywords

MeSH

DOI
10.1111/jcmm.13292
PMID
28782172
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pharmacology
Ajou Authors
강, 이중  |  양, 시영
Full Text Link
Files in This Item:
28782172.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse